Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF-Reference-Cited by-同舟云学术

Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF

Published:2013-06 Issue: Volume: Page:n/a-n/a
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J. Clin. Apheresis

Author:

Chaudhary Lubna¹,Awan Farrukh²,Cumpston Aaron,Leadmon Sonia,Watkins Kathy³,Tse William³,Craig Michael,Hamadani Mehdi

Affiliation:

1. Section of Hematology and Oncology; West Virginia University; Morgantown; West Virginia

2. Section of Hematology and Oncology; Georgia Health Sciences Center; Augusta; Georgia

3. Osborn Hematopoietic Malignancy and Transplantation Program; West Virginia University; Morgantown; West Virginia

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jca.21280/fullpdf

Reference33 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

3. 3102 Investigators. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009

4. 3101 Investigators. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma;DiPersio;J Clin Oncol,2009

5. Improving stem cell mobilization strategies: future directions;Bensinger;Bone Marrow Transplant,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma;Bone Marrow Transplantation;2024-07-31

2. Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review;Pharmaceuticals;2024-07-15

3. Non-interventional Study Evaluating the Mobilization of Stem Cells by Plerixafor Before Salvage Autologous Stem Cell Transplant in Relapsed Multiple Myeloma (IFM-2015-03);Clinical Hematology International;2023-02-12

4. Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF +/−plerixafor vs cyclophosphamide/ GCSF +/−plerixafor;Journal of Clinical Apheresis;2022-02-26

5. Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era;Transplantation and Cellular Therapy;2021-07